Clinical Trial Update: Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on pioglitazone for heart failure with preserved ejection fraction in adults with type 2 diabetes mellitus; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type 2 Diabetes Mellitus in Obese, Heart Failure With Preserved Ejection Fraction | Phase 4 | Status: RECRUITING